Suppliers / Cheng Fong Chemical

Cheng Fong Chemical

Taiwan Updated 9 July 2026

Cheng Fong Chemical is an API manufacturer based in Taiwan. It holds 14 active US drug master files across a filed portfolio of 6 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 2 August 2024 as VAI.

14
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 2 August 2024 VAI US FDA
  • 30 August 2019 VAI US FDA
  • 9 March 2018 VAI US FDA
  • 14 April 2017 OAI US FDA
  • 22 April 2016 OAI US FDA
  • 12 April 2013 VAI US FDA
  • 17 February 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Taiwan, Taiwan 1000174711

What they file, and where

Molecule Regulators Docs
Pseudoephedrine US FDA 4
Diclofenac US FDA 2
Mefenamic Acid US FDA 2
Phenylephrine US FDA 2
Phenylpropanolamine US FDA 2
Procainamide US FDA 2

Also appears on these molecule pages

Diclofenac API Mefenamic Acid API Phenylephrine API Pseudoephedrine API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Cheng Fong Chemical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 2 August 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates